Table 3.
Malondialdehyde, uric acid, and superoxide dismutase levels in mild and severe malarial patients during Plasmodium vivax, Plasmodium falciparum, and mixed infections
| Parameter | Pv (n=48) | Pf (n=13) | Mixed (n=10) | P*(between SM groups) | |||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
||||||
| MM | SM | MM | SM | MM | SM | Pv versus Pf | Pv versus mixed | Pf versus mixed | |
| Number of study participants | 35 (72.9) | 13 (56.5) | 7 (14.6) | 6 (26.1) | 6 (12.5) | 4 (17.4) | 0.031 | 0.254 | 0.232 |
| Parasitemia (%) | 0.2±0.1 | 0.5±0.4 | 0.4±0.2 | 0.9±0.4 | 0.4±0.2 | 0.5±0.3 | 0.0285 | 0.1697 | 0.0376 |
| MDA | 1.9±1.0 | 3.5±2.1 | 1.5±1.1 | 6.9±0.8 | 1.3±1.0 | 3.9±1.0 | 0.0015 | 0.7209 | 0.0095 |
| UA | 6.2±2.0 | 7.8±1.6 | 5.9±3.4 | 11.7±2.0 | 3.7±2.9 | 8.0±2.0 | <0.0001 | 0.5008 | 0.0571 |
| SOD | 29.9±9.4 | 19.0±6.3 | 32.4±10.3 | 13.3±4.2 | 38.9±7.8 | 16.9±5.6 | 0.045 | 0.5008 | 0.281 |
Data represented as mean±SD; comparison of two groups by Mann–Whitney U-test and Kruskal–Wallis test for comparison between three groups. *P<0.05 was considered to be significant and are highlighted in bold. MDA: Malondialdehyde, UA: Uric acid, SOD: Superoxide dismutase, SD: Standard deviation, Pv: Plasmodium vivax, Pf: Plasmodium falciparum